Market Tracker

08/20 2:29pm ET

Impax Laboratories Inc (NASDAQ:IPXL)

24.29
Data as of 2:13pm ET
 -0.19 / -0.78%
Today’s Change
19.39
Today|||52-Week Range
31.04
-3.38%
Year-to-Date
No recent news for Impax Laboratories Inc.

Today’s Trading

Previous close24.48
Today’s open24.35
Day’s range24.25 - 24.67
Volume217,044
Average volume (3 months)735,696
Market cap$1.7B
Dividend yield--
Data as of 2:13pm ET, 08/20/2014

Growth & Valuation

Earnings growth (last year)+79.27%
Earnings growth (this year)+41.34%
Earnings growth (next 5 years)+26.24%
Revenue growth (last year)-12.07%
P/E ratio1,214.5
Price/Sales3.29
Price/Book2.11

Competitors

 Today’s
change
Today’s
% change
MDCOMedicines Co-0.29-1.10%
RAREUltragenyx Pharmaceu...+0.27+0.48%
GWPHGW Pharmaceuticals P...-0.35-0.38%
IRWDIronwood Pharmaceuti...-0.04-0.30%
Data as of 2:28pm ET, 08/20/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)$0.30
Annual revenue (last year)$511.5M
Annual profit (last year)$101.3M
Net profit margin19.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President &
Chief Executive Officer
George Frederick Wilkinson
Chief Financial Officer &
Senior VP-Finance
Bryan M. Reasons
Corporate headquarters
Hayward, California

Forecasts